Special Report 2023 Q1: Advancing IP Diversity

Data shows that pharmaceutical and medical device companies are going considerably further than those in the technology sector to diversify named inventors on patents. Life sciences firms have valuable lessons to offer Big Tech about successful methods for attracting diverse innovators and giving them equal access to the patenting process.

We take heart at the 2021 Diversity Pledge, which has attracted at least 50 signatories – including P&G, Lenovo, Microsoft, Google, Meta Platforms, AT&T and Ericsson. All signatories have committed to collect and analyse data on their innovators, choose a diversification goal, implement solutions and track results. In this special report, several of these corporates fly the flag for greater inclusion by sharing their stories and talking frankly about the methods that are working for them.

IAM Insight Panel Report: H2 2022

IAM panel reports are based on a regular survey of decision makers working inside IP owning entities, law and attorney firm partners, and senior executives at service providers. This report provides critical insight into issues such as portfolio management, budgeting, litigation, monetisation and the regulatory environment.